secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-08-25T23:59:59+00:00
Accession:  0001501697-25-000008
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals board members McGirr and Woods resign; audit committee reconstituted
--------------------------------------------------------------------------------

- David McGirr and R. Keith Woods resigned from the board effective August 22, 2025, with no disagreement.
- Michael Wyzga appointed as chair of the audit committee.
- Francoise de Craecker and Gary Bridger appointed as members of the audit committee.
- Resignations cover all committees; departure not related to operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000150169725000008/0001501697-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000150169725000008/xfor-20250822.htm
  HTML page:      https://secwatch.observer/filing/0001501697-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer